Moderna Stock Target Price and Analyst Consensus

MRNA Stock  USD 33.61  1.37  3.92%   
The current analyst and expert consensus on Moderna is Buy with 14 hold recommendations. The current projected Moderna target price consensus is 73.64 with 26 analyst opinions. One of the most common ways Moderna analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Moderna vendors, executives, and/or customers. Moderna recommendation module provides expert sentiment on the projected Moderna target price to derive its highest and lowest estimates based on target price standard deviation of 5.1686.
Lowest Forecast
67.01
Highest Forecast
81.74
Target Price
73.64
The current year's Gross Profit is expected to grow to about 3.5 B, whereas Pretax Profit Margin is forecasted to decline to (0.54). At present, Moderna's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 16.7 B, whereas Total Current Liabilities is forecasted to decline to about 2.4 B.
  
It's important to approach Moderna's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Moderna Target Price Consensus

Moderna target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Moderna's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   26  Buy
Most Moderna analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Moderna stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Moderna, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Moderna Target Price Projection

Moderna's current and average target prices are 33.61 and 73.64, respectively. The current price of Moderna is the price at which Moderna is currently trading. On the other hand, Moderna's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Moderna Market Quote on 7th of February 2025

Low Price33.61Odds
High Price35.24Odds

33.61

Target Price

Analyst Consensus On Moderna Target Price

Low Estimate67.01Odds
High Estimate81.74Odds

73.6418

Historical Lowest Forecast  67.01 Target Price  73.64 Highest Forecast  81.74
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Moderna and the information provided on this page.

Moderna Analyst Ratings

Moderna's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Moderna stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Moderna's financials, market performance, and future outlook by experienced professionals. Moderna's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Moderna price targets

Moderna's stock target price is an estimate of its future price, usually made by analysts. Using Moderna's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Moderna's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Moderna's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Moderna Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Moderna is a key component of Moderna valuation and have some predictive power on the future returns of a Moderna.
Hype
Prediction
LowEstimatedHigh
28.3733.6138.85
Details
Intrinsic
Valuation
LowRealHigh
26.4931.7336.97
Details
Naive
Forecast
LowNextHigh
25.2230.4635.69
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-2.45-2.28-1.82
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Momentum Idea
Momentum
Invested over 60 shares
Banking Idea
Banking
Invested over 30 shares
FinTech Idea
FinTech
Invested over 60 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Investor Favorites Idea
Investor Favorites
Invested over 300 shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested few shares
Small Cap ETFs Idea
Small Cap ETFs
Invested over 100 shares
Strategy ETFs Idea
Strategy ETFs
Invested over 200 shares
Large Cap ETFs Idea
Large Cap ETFs
Invested over 500 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 300 shares
When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:
Check out Macroaxis Advice on Moderna to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Please note, the presentation of Moderna's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Moderna's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Moderna's management manipulating its earnings.